| Alnylam Pharmaceuticals, Inc. | $21.4b | $165.35 | +5.3% | 3.0M | |
| Arrowhead Research Corporation | $8.4b | $47.63 | +1.3% | 2.7M | |
| Ionis Pharmaceuticals, Inc. Common Stock | $6.7b | $28.92 | +6.4% | 4.7M | |
| Wave Life Sciences Ltd. Ordinary Shares | $0.7b | $3.12 | -0.5% | 2.0M | |
| CAMP4 Therapeutics Corporation Common Stock | $240.3m | $3.77 | -8.3% | 27.4K | |
| Cartesian Therapeutics, Inc. Common Stock | $193.9m | $6.35 | -0.6% | 94.2K | |
| ProQR Therapeutics N.V. Ordinary Shares | $193.3m | $1.40 | +2.9% | 558.4K | |
| Atrium Therapeutics, Inc. Common Stock | $149.2m | $7.51 | 0.0% | 173.5K | |
| Eloxx Pharmaceuticals, Inc. Common Stock | $42.0m | $13.18 | -0.2% | 10.7K | |
| Phio Pharmaceuticals Corp. Common Stock | $10.5m | $0.81 | -5.0% | 62.9K | |
| Exicure, Inc. Common Stock | $6.6m | $0.99 | 0.0% | 6.6K |